Taltz ® (ixekizumab) injection

80 mg/mL

The below information is provided in response to your request and may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above.

TALTZ® (ixekizumab): Monitoring Plasma Levels of Ixekizumab

There are no recommendations for monitoring ixekizumab drug levels, or for adjusting ixekizumab dose based on blood levels.

There are no recommendations for monitoring ixekizumab drug levels, or for adjusting ixekizumab dose based on blood levels. At this time, no commercially available assays are available.


Enclosed Prescribing Information

TALTZ® (ixekizumab) injection, for subcutaneous administration, Lilly

Reference

TALTZ® [package insert]. Indianapolis, IN: Eli Lilly and Company; 2016.

Additional related information

Date of Last Review: February 24, 2017

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 8pm ET

Or you can

Ask us a question Chat with us

Submit a question

Visit Us @LillyMedical